On July 2, 2015, she was submitted to an uneventful percutaneous PFO occlusion using a Cardia Intrasept™ prosthesis (CARDIA, Inc., Burnsville, MN, USA). Intraoperative three-dimensional transesophageal echocardiography confirmed correct prosthesis positioning and absence of residual shunt through the bubble test. Current guidelines of the two most important international societies of echocardiography, the European Association of Cardiovascular Imaging and the American Society of Echocardiography, determine that the three-dimensional echocardiography is the echocardiographic modality of choice for monitoring, following and guiding percutaneous procedures performed in hemodynamics and hybrid rooms, as in this case. 1
The patient was discharged on the first postoperative day. After 30 days, adequate placement of the device was confirmed with PFO occlusion through transthoracic echocardiography. The patient remains in outpatient care, with migraine improvement.
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